![PDF) Communication policies, good governance and development journalism | Jan Servaes - Academia.edu PDF) Communication policies, good governance and development journalism | Jan Servaes - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/30762877/mini_magick20190426-26278-1541qak.png?1556317964)
PDF) Communication policies, good governance and development journalism | Jan Servaes - Academia.edu
![Media Practice and Everyday Agency in Europe (2014) | Leif Kramp, Nico Carpentier, Ebba Sundin, and Hannu Nieminen - Academia.edu Media Practice and Everyday Agency in Europe (2014) | Leif Kramp, Nico Carpentier, Ebba Sundin, and Hannu Nieminen - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/35331825/mini_magick20220710-23916-gpb6xc.png?1657513019)
Media Practice and Everyday Agency in Europe (2014) | Leif Kramp, Nico Carpentier, Ebba Sundin, and Hannu Nieminen - Academia.edu
![Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022 | ACS Infectious Diseases Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022 | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.2c00253/asset/images/large/id2c00253_0003.jpeg)
Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022 | ACS Infectious Diseases
![Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022 | ACS Infectious Diseases Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022 | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.2c00253/asset/images/large/id2c00253_0012.jpeg)
Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022 | ACS Infectious Diseases
![Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms - ScienceDirect Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004221000365-gr1.jpg)
Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms - ScienceDirect
![PDF) CEDAR Phase 1 outcomes: Special issue of Participations, May 2016 | Ranjana Das and Miriam Stehling - Academia.edu PDF) CEDAR Phase 1 outcomes: Special issue of Participations, May 2016 | Ranjana Das and Miriam Stehling - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/46499765/mini_magick20190209-25274-llsaaa.png?1549755767)
PDF) CEDAR Phase 1 outcomes: Special issue of Participations, May 2016 | Ranjana Das and Miriam Stehling - Academia.edu
![Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022 | ACS Infectious Diseases Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022 | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.2c00253/asset/images/large/id2c00253_0005.jpeg)